Ace Health Desk – In short: The Therapeutic Goods Administration has announced Andrographis paniculata will no longer be able to be classified as a low-risk ingredient. The herb is in dozens of cold and flu supplements linked to anaphylaxis and other severe allergic reactions: Published: Tue 22 Sep 2026 at 7:01amBy NSW investigative reporter Joanna Woodburn What’s next? […]
-
Subscribe
Subscribed
Have a WordPress.com account? Log in now.
